Trials / Completed
CompletedNCT01766843
Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus
Bioequivalence Study Comparing Two Salmeterol/Fluticasone Propionate Dry Powder Inhalers, SF Easyhaler and Seretide Diskus 50/500 Mcg/Inhalation; Randomised, Double-blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the test product Salmeterol/fluticasone Easyhaler with the reference product Seretide Diskus in terms of drug absorbed in the bloodstream.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Seretide Diskus and charcoal | 2 inhalations as a single dose |
| DRUG | Seretide Diskus | 2 inhalations as a single dose |
| DRUG | SF Easyhaler and charcoal | 2 inhalations as a single dose |
| DRUG | SF Easyhaler | 2 inhalations as a single dose |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2013-01-11
- Last updated
- 2014-01-03
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01766843. Inclusion in this directory is not an endorsement.